Scientists at Newcastle University have successfully used a pioneering three-person IVF technique to spare eight children in the UK from potentially fatal genetic diseases. This method, which remains banned in the United States, could reshape the future of reproductive medicine.
How the Technique Works: Replacing Faulty Mitochondria
As reported by Reuters, the procedure involves transferring the nuclear DNA from a fertilized egg—containing genetic material from both the mother and father—into a donor egg that has had its own nucleus removed. This donor egg retains healthy mitochondria, the tiny powerhouses inside cells responsible for energy production.
By replacing the mother’s faulty mitochondrial DNA (mtDNA) with healthy mtDNA from the donor, doctors can prevent the inheritance of incurable and life-threatening disorders. These disorders often affect organs that demand high energy, such as the brain, heart, liver, muscles, and kidneys.
Healthy Outcomes for the First Eight Children
Of the eight children born through this technique:
- One is now two years old
- Two are between one and two years old
- Five are infants
All children were born healthy, with blood tests showing no or low levels of mitochondrial mutations. They have also demonstrated normal developmental progress, according to findings published in the New England Journal of Medicine.
Years of Work Behind the Breakthrough
Dr. Andy Greenfield, a reproductive medicine expert from the University of Oxford (not involved in the study), praised the achievement. He noted that the success reflects decades of collaborative effort—spanning scientific innovation, ethical debate, public and patient engagement, legal regulation, and long-term monitoring frameworks for both mothers and infants.
The IVF Process in Detail
In typical IVF screenings, doctors may find low-risk eggs with minimal mitochondrial mutations, which are considered safe for implantation. However, when all of a mother’s eggs carry high levels of mtDNA mutations, this advanced method becomes essential.
Here’s how the process unfolds:
- Doctors fertilize the mother’s egg with the father’s sperm.
- They remove the pronuclei—the egg and sperm nuclei containing parental DNA.
- They transfer these pronuclei into a donated fertilized egg, which has had its own pronuclei removed.
This allows the resulting embryo to develop using healthy mitochondria from the donor, while still carrying the biological parents’ genetic blueprint.
Dramatic Reduction in Mitochondrial Mutations
In a second paper published by the same team, senior researcher Professor Mary Herbert highlighted the effectiveness of the method. Blood samples from six babies showed 95–100% reductions in mtDNA mutations. In two others, mutation levels dropped by 77–88% compared to their mothers.
“These results clearly demonstrate that pronuclear transfer effectively reduces the transmission of mitochondrial DNA diseases,” the researchers stated.
Encouraging Results from Initial Trials
The study involved 22 women who had a high risk of passing mitochondrial diseases to their children. Of these:
- Eight women delivered healthy babies
- One woman is currently pregnant
- Seven pregnancies were uneventful
- One woman showed elevated lipid levels during pregnancy
Importantly, no miscarriages occurred during the trial.
Why This Method May Be More Reliable
Researchers also explored a second method—transplanting the nucleus of an unfertilized egg into a donor egg before fertilization. However, they concluded that pronuclear transfer after fertilization appears more reliable in preventing genetic transmission.
UK Leads in Legalizing Mitochondrial Donation Research
In 2015, the UK became the first country to legalize mitochondrial donation for human reproduction. That same year, the United States effectively banned the technique through a congressional appropriations bill, which prohibited the FDA from funding research into heritable genetic modification.